NewsAsia Bringing you the latest Business News from the Science Industry By Gwyneth Astles
Agilent Technologies Appoints New South East Asia Regional Manager for the Life Sciences Group in Southeast Asia Region
Agilent Technologies have announced the appointment of Dr Sam Mohan as the Southeast Asia Regional Manager for the Life Sciences Group.
Based in Singapore, Dr Mohan will report to Rod Minett, General Manager of South- Asia Pacific and Korea Field Operations, Life Sciences Group, and will be responsible for managing all the life sciences’ sales channels in South East Asia. This comprises building the company’s product strategy, implementation, lifecycle management and
partner integration, combined with overseeing all global brand and communications activities.
Prior to joining Agilent Technologies, Dr Mohan was the Sales Director of Cell Biosciences, responsible for the company’s sales and marketing activities for distributors within the Pacific Rim area. He was also the Sales Manager at Amersham Biosciences and spent seven years managing the Bio-Rad Laboratories’ Life Sciences and Clinical Diagnostics product range.
“Dr Mohan has over 16 years of experience in the biosciences industry and is a world-class and very experienced manager,” said Rod Minett.
“His appointment brings a wealth of talent and experience to Agilent Technologies, which will assist us in developing and growing our business. Over the past year, we have worked hard to ensure we have the right people on the ground and Dr Mohan’s appointment is an integral part of that growth plan,” Minett added.
Dr Sam Mohan TO FIND OUT MORE CIRCLE NO. 305
Sotax opens Indian
Subsidiary
Cellmid Signs Antibody Humanisation Collaboration Cellmid Ltd has signed a collaboration
agreement with Antitope Ltd for the humanisation of its lead therapeutic monoclonal antibody candidate. The collaboration is expected to deliver a drug candidate, a first in class humanised anti- midkine antibody, using Cellmid’s patented sequence and Antitope’s proprietary EpiScreen™ and Composite Human Antibody™ technologies.
As part of the agreement Antitope will also produce sufficient humanised antibody for preclinical testing using their proprietary high yielding CHO expression system.
Cellmid’s lead will be humanised by Antitope using their proprietary Composite Human Antibody™ technology. Composite Human Antibody™ technology is a proven platform for rapid generation of non-immunogenic, fully humanised candidates, with similar or better binding affinities than the template antibody. Additionally, Antitope’s Composite Human AntibodyTM technology is clear of all the dominant patents in the humanisation space, thus avoiding the need for Cellmid to pay royalties to third parties.
“We have conducted an extensive global search to find the right humanisation partner
Freeman Technology appoints Asia Dr Ramaswamy, MD, Sotax India
Swiss based Sotax, specialists in providing high quality dissolution testing systems, composite assay and content uniformity workstations and physical tablet testing instruments for pharmaceutical industry throughout the world, recently opened its subsidiary in India as Sotax India Pvt Ltd, with their corporate office in Mumbai.
This move will help to service Indian pharmaceutical manufacturers and R&D centres in a better way.
Initially Sotax India will focus two hundred plus pharma manufacturing and R&D locations with their systems in India. Sotax India will also initiate workshops and seminars as value addition to QA, QC, manufacturing and R&D department people in Indian pharmaceutical industry.
Sotax has appointed Dr L Ramaswamy as the Managing Director of their Indian subsidiary. Dr Ramaswamy, with his three decades of Indian pharmaceutical industry experience, has charted out a road map for Sotax India for next five years.
TO FIND OUT MORE CIRCLE NO. 308
Distributors for FT4 Powder Rheometer Powder characterisation company Freeman Technology is significantly expanding its activities in Asia with the appointment of distribution partners in the region who will sell and support the company’s FT4 Powder Rheometer. DKSH, an established organisation which operates in 35 countries and has a particular focus on Asia, will be Freeman Technology’s distribution partner in Singapore, Malaysia, Thailand and Taiwan. In India Freeman Technology will partner with Aimil Ltd, a highly respected distributor of analytical instrumentation, which serves the Indian market via 10 offices around the country and some 50 channel partners.
According to Freeman Technology’s Director of Operations, Tim Freeman, the growing demand for the company’s universal powder tester in these dynamic markets means that additional local support is now needed. "Freeman Technology has been working in powder characterisation for the past 10 years and today the FT4 Powder Rheometer is used all around the world," said Tim Freeman. "For some years we have had a direct presence in Europe and the US and a distribution partner in Japan. While a dedicated team at our headquarters in the UK provides excellent sales and technical support to customers
Graffinity Enters into Drug Discovery
Collaboration with Shionogi Graffinity Pharmaceuticals GmbH, a member of the NovAliX group of companies, have announced that it has entered into a research collaboration with Osaka, Japan based Shionogi & Co, Ltd Under the terms of the agreement, Graffinity will receive technology access fees and payments for follow-up chemistry for the
generation of various, novel small molecule hits against a key drug target. Financial details of the transaction were not disclosed. Mathias Woker, Chief Business Officer of Graffinity, remarked:, ”We are pleased that Shionogi has chosen to collaborate with us to apply our fragment based screening platform to one of Shionogi’s high
priority discovery programs. This marks our first collaboration with a leading Japanese pharmaceutical company. Our proprietary assay/label-free SPR primary screen of 24,000 fragments and 87,000 leadlike molecules is often crucial in addressing drug targets that are difficult to screen with other technologies.”
TO FIND OUT MORE CIRCLE NO. 309
everywhere, there is now so much interest in Asia that the time is right for us to extend the local services we offer. I am delighted to be working with such long established and well respected companies as DKSH and Aimil." The FT4 Powder Rheometer is a universal powder tester that uses patented dynamic methodology, fully automated shear cells and several bulk property tests, including density, compressibility and permeability to quantify powder properties in terms of flow and processability. Correlating this data with processing performance enables users to optimise powder processes.
TO FIND OUT MORE CIRCLE NO. 307
for our anti-midkine assets. Antitope’s technical pedigree placed them on the top of our preferred humanisation experts,” said Cellmid CEO Maria Halasz.
“We are delighted to be working with Cellmid to assist with their drug discovery programs” said Dr Matthew Baker, Chief Scientific Officer and co-founder of Antitope, adding; "We are excited about the prospects for Cellmid’s therapeutic antibody against midkine and believe the development of fully humanised, non-immunogenic Composite Human Antibodies will support the development of safe and effective therapies.”
TO FIND OUT MORE CIRCLE NO. 306
To be included in our next issue, send all your Business and Financial News stories to
gwyneth@intlabmate.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
